Disease is poised to wipe out much of Africa’s rice crop. Still-unapproved gene edited varietals may be the only hope

Credit: Eyenor via CC-BY-SA-4.0
Credit: Eyenor via CC-BY-SA-4.0

A new study has found that CRISPR technology can be used to edit genes in some strains of rice, developing resistance.

Rice is a key staple crop in sub-Saharan Africa, with more than 60% of rice produced consumed there. However, the Rice Yellow Mottle Virus (RYMV) causes a disease that has the propensity to wipe out African rice crops.

Many of Africa’s rice producers have barely a hectare of land to themselves. In this environment, between 10% and 100% of rice yield is regularly lost to disease, putting strain on food security.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

One of the researchers, Wolf B. Frommer, is an investigator at the Healthy Crops project, an international research consortium whose broad aim is to help smallholder African and Asian rice farmers increase yields and avoid diseases.

“We now also have edited blight resistant rice, especially relevant due to a major outbreak caused by the inadvertent introduction of Asian strains to East Africa, with major damage and rapid spread,” Frommer told FoodNavigator.

“We also have lines for Tanzania and East Africa that are resistant, and did not use editing, maybe not as good as the edited lines, but due to regulatory situation the best possible solution.”

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of how  the White House embraced the fringe claim that scientists are being mysteriously murdered
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.